Curated News:


Add to Favorites Subscribe Share
Press "esc" to clear
Press "esc" to clear
Press "esc" to clear
Go to Advanced Search

Showing results

110 of 296
  • Embargo expired:
    17-Mar-2019 11:45 AM EDT

Article ID: 709622

Absorbable Antibiotic Envelope Can Significantly Cut Cardiac Device Infections, Cleveland Clinic Study Shows

Cleveland Clinic

A Cleveland Clinic-led research team has found that using an absorbable, antibiotic-eluting envelope when implanting cardiac devices like pacemakers and defibrillators can cut the rate of major infections by 40 percent. The research was presented today at the American College of Cardiology’s 68th Annual Scientific Session and simultaneously published in the New England Journal of Medicine. It will also be presented tomorrow at the European Heart Rhythm Association 2019 Congress.

14-Mar-2019 11:05 AM EDT

Article ID: 709653

Northwestern Medicine Expert and Co-Chair of the PARTNER 3 Case Review Board S. Chris Malaisrie, MD, available for Comment on Low-Risk TAVR

Northwestern Medicine

S. Chris Malaisrie, MD, a cardiac surgeon at Northwestern Memorial Hospital, associate professor of surgery (cardiac surgery) at Northwestern University Feinberg School of Medicine and co-chair of the PARTNER 3 case review board, is available to comment on PARTNER 3.

16-Mar-2019 9:00 AM EDT
  • Embargo expired:
    13-Mar-2019 5:00 PM EDT

Article ID: 709406

Dramatic Shifts in First-time Opioid Prescriptions Bring Hope, Concern

Harvard Medical School

Analysis shows the monthly rate of first-time opioid prescriptions dropped by more than half between 2012 and 2017. Though some physicians wrote no new prescriptions at all, others continued to prescribe dosages and durations that put patients at risk for misuse, overdose and death. Findings underscore importance of nuanced, individualized prescribing over all-or-nothing approach.

11-Mar-2019 1:00 PM EDT

Article ID: 709041

Hypertension Study Based in African-American Barbershops Honored


The Clinical Research Forum recognized the Cedars-Sinai's Smidt Heart Institute with a 2019 Top Ten Clinical Research Achievement Award today for its study aimed at developing a blood pressure control program for African-American men in the comfortable and convenient environments of their barbershops. In just six short months, the study improved the outcomes and control of high blood pressure in more than 60 percent of participants.

4-Mar-2019 12:05 PM EST
  • Embargo expired:
    21-Feb-2019 5:00 PM EST

Article ID: 708172

New “Smart Drug” Shows Promise for Metastatic Triple-Negative Breast Cancer

Columbia University Irving Medical Center

A clinical trial at NewYork-Presbyterian/Columbia and other centers found that patients responded to a new “smart drug” for women with an aggressive form of breast cancer.

15-Feb-2019 11:05 AM EST
  • Embargo expired:
    20-Feb-2019 5:00 PM EST

Article ID: 708343

CASSINI Trial publishes data on preventing blood clots in cancer patients

Fred Hutchinson Cancer Research Center

The first clinical study investigating the use of the direct oral anticoagulant, rivaroxaban, to prevent blood clots in patients with cancer at high-risk published today in the New England Journal of Medicine. The study found no significant reduction in venous thromboembolism or death in the overall 180-day trial period; however, the researchers did observe a lower incidence of these events while patients were actively on the study drug, or during the on-treatment period.

19-Feb-2019 4:05 PM EST
  • Embargo expired:
    18-Feb-2019 2:00 PM EST

Article ID: 708157

Helping Patients Breathe During Dangerous Procedure Prevents Life-Threatening Complications

Vanderbilt University Medical Center

Thousands of Americans die each year during a dangerous two-minute procedure to insert a breathing tube. Now a Vanderbilt University Medical Center (VUMC) study in the New England Journal of Medicine (NEJM) is showing that using bag-mask ventilation, squeezing air from a bag into the mouth for 60 seconds to help patients’ breathing, improves outcomes and could potentially save lives.

15-Feb-2019 10:00 AM EST
  • Embargo expired:
    16-Feb-2019 5:10 PM EST

Article ID: 708091

Drug combination may become new standard treatment for advanced kidney cancer

Dana-Farber Cancer Institute

A combination of two drugs – one of them an immunotherapy agent – could become a new standard, first-line treatment for patients with metastatic kidney cancer, says an investigator from Dana-Farber Cancer Institute, reporting results from a phase 3 clinical trial.

15-Feb-2019 2:05 PM EST

Article ID: 708116

Landmark study in the New England Journal of Medicine highlights how adults can prevent infection with MRSA bacteria after hospital discharge

University of California, Irvine

Project CLEAR clinical trial finds that the application of antiseptic soap, mouthwash, and nose ointments prevent post-discharge MRSA infections and hospitalizations. Patients

14-Feb-2019 11:05 AM EST

Showing results

110 of 296

Chat now!